Cargando…
Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy
Blood-based biomarkers reflect systemic inflammation status and have prognostic and predictive value in solid malignancies. As a recently defined biomarker, Pan-Immune-Inflammation-Value (PIV) integrates different peripheral blood cell subpopulations. This retrospective study of collected data aimed...
Autores principales: | Şahin, Ahmet Bilgehan, Cubukcu, Erdem, Ocak, Birol, Deligonul, Adem, Oyucu Orhan, Sibel, Tolunay, Sahsine, Gokgoz, Mustafa Sehsuvar, Cetintas, Sibel, Yarbas, Gorkem, Senol, Kazım, Goktug, Mehmet Refik, Yanasma, Zeki Burak, Hasanzade, Ulviyya, Evrensel, Turkkan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289916/ https://www.ncbi.nlm.nih.gov/pubmed/34282214 http://dx.doi.org/10.1038/s41598-021-94184-7 |
Ejemplares similares
-
Efficacy of chemotherapeutics on classic and non-classic Kaposi sarcoma: a single-center retrospective real-world study
por: Orhan, Sibel Oyucu, et al.
Publicado: (2021) -
The Ki-67 proliferation index predicts recurrence-free survival in patients with dermatofibrosarcoma protuberans
por: Deligönül, Adem, et al.
Publicado: (2021) -
The impact of Ki-67 index, squamous differentiation, and several clinicopathologic parameters on the recurrence of low and intermediate-risk endometrial cancer
por: Ocak, Birol, et al.
Publicado: (2021) -
Correlation between Ubiquitin E3 Ligases (SIAHs) and Heat Shock Protein 90 in Breast Cancer Patients
por: Sabour Takanlou, Leila, et al.
Publicado: (2022) -
Role of Neoadjuvant Chemotherapy in Non-small Cell Lung Cancer in the COVID-19 Pandemic
por: Karaman, Elanur, et al.
Publicado: (2022)